Invested
February 2025
Status
Corporate HQ
California, US

Avid is a leading specialised CDMO with state-of-the art facilities and expertise in bioprocess optimisation, delivering industry-leading complex biologics to biotechnology and pharmaceutical companies.

Avid boasts an exceptional quality and regulatory track record, demonstrating a proven ability to deliver products from clinical stages through to commercial launch across a range of modalities, effectively supporting the biologics pipeline.

Enablement & Alignment
Fulfil growth within existing capacity and optimise go-to-market strategy through investment into Business Development and Marketing teams and infrastructure to create a global platform of scale
Capability & Capacity
Support both upstream and downstream expansion to broaden Avid’s capabilities and achieve full integration, positioning it as a segment leader with unique combination of capabilities, capacity and expertise
Building Strategic Footprints
Opportunity to expand manufacturing capacity in the East Coast and Europe, establishing a transatlantic footprint that will facilitate growth of a commercial presence and customer base in these regions